Novus Therapeutics, Inc. Exchange Agreements
5 Contracts & Agreements
- Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein (Filed With SEC on January 13, 2022)
- Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
- Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on February 19, 2020)
- Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked ***and has been filed separately with the Securities and Exchange Commission pursuant to a... (Filed With SEC on August 9, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MASTER LICENSE AGREEMENT BETWEEN UNIVERSITY... (Filed With SEC on August 11, 2014)